SAP News

Hannah Nivens, CPhT, a pharmacy distribution specialist at Novant Health Pharmacy Administration, discusses pharmacy distribution for pharmacy technicians.

As evidence for omega-3 continues to develop, pharmacists remain poised to guide patients toward the most indicated, safe, effective, and convenient options available.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss the importance of diverse representation.

Cabotegravir showed promising results in preventing HIV transmission in men, women, and transgender women with similar rates of adverse events to oral PrEP options.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss what being a Black health care workers means to them.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss how they became pharmacy technicians in health-system pharmacies.

Each therapy presents a different but effective treatment option.

Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.

Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.

HER2-low disease demands a different approach from that of HER2-negative disease.

PARP inhibitors in particular have changed the therapeutic landscape for EOC.

Numerous clinical trials are investigating the next generation of PARPi.

Approval of a novel antibody-drug conjugate ushers in new second-line option.

Academic and industry partnership to investigate new approach to treating lethal pancreatic cancer.

These agents are likely to become the mainstay of cancer treatment in the very near future.

Branding Move and Leadership Additions Part of Effort to Deliver “One City of Hope” Experience to Patients Across National Clinical Network.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

New UC Davis study finds relationship between tumor microbiome and immune system in patients with soft tissue sarcoma.

Luke Gormley, PharmD, BCPS, discusses how pharmacists are involved in the management of inclisiran.

Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial

AON celebrates its Board of Managers’ appointments and retirements.

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.

Participants Will Attend PQA Annual Meeting, Have Access to More Than 20 Hours of Training.

To help advance patient care and address health equities for underserved communities, McKesson is investing in certified pharmacy technicians who are passionate about making a difference.

The incidence of vancomycin-resistant enterococci has nearly doubled in recent years.

Significant study results may help inform clinical practice strategies.

Developments may soon impact clinical practice in hematology and oncology.

Researchers question screening guidelines for older women after findings.